The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Sp921
MANAGEMENT OF INCIDENTALLY DETECTED COLORECTAL NEUROENDOCRINE TUMORS
Date
May 8, 2023
Explore related products in the following collection:
This session is co-sponsored by the North American Neuroendocrine Tumor Society (NANETS).
Clinically focused session focused on management of incidentally discovered neuroendocrine tumors, with a specific focus on the role of the gastroenterologist in this management. The session will have talks focused on incidentally discovered neuroendocrine tumors including gastroduodenal neuroendocrine tumors, pancreatic neuroendocrine tumors, and colorectal neuroendocrine tumors. Incidental identification of gastroenteropancreatic neuroendocrine tumors is becoming increasing common in gastroenterology practice, and therefore gastroenterologists need to understand how to manage these tumors when they are encountered.
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
BACKGROUND AND AIMS: Chemoresistance is a major cause of colorectal cancer (CRC) recurrence and death. The critical role of gut microbiome in the efficacy of CRC chemotherapy remains unclear…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…